EXAS Cologuard: Prakiraan wutah bathi kanggo taun ngarep
Exact Sciences aims for global leadership in early cancer detection through the expansion of home tests and liquid biopsies. This chart in the GURU.Markets terminal illustrates the expected growth in earnings per share for next year, where the figure stood at 1890.10. This confirms revenue stability driven by insurance reimbursements, while logistics optimization via outsourcing reduces the burden on laboratories.
Rincian analitis perusahaan Exact Sciences
- rega lan prakiraan konsensus rega:
- data kapitalisasi saham perusahaan:
- indikator kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Exact Sciences|EXAS - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Exact Sciences Corporation|EXAS - Tanggungan utang kumulatif perusahaan|Utang marang nilai buku Exact Sciences|EXAS - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Exact Sciences|Rasio cepet exactsciences.com
- statistik bathi lan rasio pasar:
EXAS - Penghasilan resik|Proyeksi bathi mangsa ngarep Exact Sciences|EXAS - Periode bali modal bisnis|Pangali Forward P/E Exact Sciences|EXAS - Rega marang bathi kanthi panyesuaian wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Exact Sciences|EXAS - Bathi operasional sadurunge amortisasi|Bathi resik saben saham (EPS TTM) Exact Sciences|EXAS - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan exactsciences.com|EXAS - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Exact Sciences
Pambiji fundamental:Cologuard
The fundamental value of shares depends directly on the expected dynamics of net earnings per share. This indicator measures the percentage change in EPS, reflecting the analysts' consensus forecast for the business's future profitability. By analyzing the growth rate model for the coming year, an investor assesses the sustainability of cash flows. For Exact Sciences (EXAS), this trend confirms the effectiveness of its expansion into the liquid biopsy and at-home screening segments.
Analisis pesaing Exact Sciences
Prakiraan wutah bathi resik saben saham kanggo taun ngarep Agilent Tech|Quest Corp (DGX) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep ILMN|RVTY - Prakiraan wutah bathi resik saben saham ing taun ngarep|Bio-Rad - Prakiraan wutah bathi saben saham kanggo taun ngarep|NNNN: Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Sterigenics - Prakiraan wutah bathi kanggo taun ngarep|QDEL - Prakiraan wutah bathi kanggo taun ngarep|OPK: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep CareDx|Prakiraan wutah bathi saben saham kanggo taun ngarep MRVI|FLGT (Fulgent Genetics Inc) - Proyeksi tambahing bathi saben saham ing taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep LAB (Fluidigm)|CTKB (Cytek Corp) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep OraSure Technologies OSUR|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Exagen Inc (XGN)|MDxHealth - Prakiraan wutah bathi kanggo taun ngarep|Lucid Diagnostics, Inc. (LUCD) - Prakiraan wutah bathi saben saham kanggo taun ngarep|PRE: Prakiraan wutah bathi kanggo taun ngarep|IMDX - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|TRIB (Trinity Biotech PLC) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep prophaselabs.com PRPH|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Ainos (AIMD)|Co-Diagnostics Inc - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep HSCS (Heart Test Laboratories Inc.)|BMRA - Prakiraan wutah bathi saben saham kanggo taun ngarep|Cardio Diagnostics Holdings, Inc. - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep onconetix.gcs-web.com|Virax Biolabs (VRAX) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|BJDX - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|AWH (Vermillion) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Accelerate Diagnostics Inc AXDX|Prakiraan wutah bathi saben saham kanggo taun ngarep CNTG (Centogene NV)|enzo.com - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep FRES (Fresh2 Group)|Prakiraan wutah bathi kanggo taun ngarep Genetic Technologies Ltd GENE|ME - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Psychemedics Inc PMD
